Akers Biosciences : It’s now all about execution - Ray Akers, co-founder and executive chairman of Akers Biosciences 00:00:00
The company must deliver on its goals now it has all the building blocks in place after its recent sales and marketing push. Yesterday, the group revealed sales of its test for people with an allergy to blood thinner Heparin more than doubled in 2014. Akers says the company is set to turn cash flow positive this year, meaning it currently has no plans to return to the market for more funds.
